Hepatoprotective effects of berberine on carbon tetrachloride-induced acute hepatotoxicity in rats

Chinese Medicine

Volumn 5, Issue , 2010, Pages

  Feng, Yibin ^a   Siu, Ka Yu ^a   Ye, Xingshen ^a   Wang, Ning ^a   Yuen, Man Fung ^b   Leung, Chung Hang ^c   Tong, Yao ^a   Kobayashi, Seiichi ^d  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BERBERINE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT;

EID: 77956585004     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-5-33     Document Type: Article

References (13)

1. Clawson GA. Mechanism of carbon tetrachloride hepatotoxicity. Pathol Immunopathol Res 1989, 8:104-112. 10.1159/000157141, 2662164.
2. Recknagel RO, Glende EA, Dolak JA, Waller RL. Mechanism of carbon tetrachloride toxicity. Pharmacol Ther 1989, 43:139-154. 10.1016/0163-7258(89)90050-8, 2675128.
3. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis Rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 2009, 126:5-17. 10.1016/j.jep.2009.08.009, 19686830.
4. Ye X, Feng Y, Tong Y, Ng KM, Tsao SW, Lau GKK, Sze CW, Zhang Y, Tang J, Shen J, Kobayashi S. Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats. J Ethnopharmacol 2009, 124:130-136. 10.1016/j.jep.2009.04.003, 19536921.
5. Yokozawa T, Ishida A, Cho EJ, Kim HY, Kashiwada Y, Ikeshiro Y. Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. J Pharm Pharmacol 2004, 56:547-556. 10.1211/0022357023024, 15099450.
6. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004, 203:127-137. 10.1016/j.canlet.2003.09.002, 14732220.
7. Hsieh YS, Kuo WH, Lin TW, Chang HR, Lin TH, Chen PN, Chu SC. Protective effects of Berberine against Low-Density Lipoprotein (LDL) oxidation and oxidized LDL-Induced cytotoxicity on endothelial cells. J Agric Food Chem 2007, 55:10437-10445. 10.1021/jf071868c, 18001034.
8. Zhu F, Qian C. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 2006, 7:78. 10.1186/1471-2202-7-78, 1693919, 17137520.
9. Peng PL, Hsieh YS, Wang CJ, Hsu JL, Chou FP. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol 2006, 214:8-15. 10.1016/j.taap.2005.11.010, 16387334.
10. Janbaz KH, Gilani AH. Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterpia 2000, 71:25-33.
11. Hwang JM, Wang CJ, Chou FP, Tseng TH, Hsieh YS, Lin WL, Chu CY. Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver. Arch Toxicol 2002, 76:664-670. 10.1007/s00204-002-0351-9, 12415430.
12. Sun X, Zhang X, Hu H, Lu Y, Chen J, Yasuda K, Wang H. Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis. Biol Pharm Bull 2009, 32:1533-1537. 10.1248/bpb.32.1533, 19721228.
13. Feng Y, Luo WQ, Zhu SQ. Explore new clinical application of Huanglian and corresponding compound prescriptions fromtheir traditional use. Zhongguo Zhong Yao Za Zhi 2008, 33:1221-1225.